GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor β and Activin-A
Open Access
- 1 January 1995
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (2) , 765-769
- https://doi.org/10.1074/jbc.270.2.765
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptorCell, 1993
- Molecular Characterization of Rat Transforming Growth Factor-β Type II ReceptorBiochemical and Biophysical Research Communications, 1993
- A carboxyl‐terminal truncated version of the activin receptor mediates activin signals in early Xenopus embryosFEBS Letters, 1992
- Transforming growth factor-β and the immune systemProgress in Growth Factor Research, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Purification and characterization of Erythroid Differentiation Factor(EDF) isolated from human leukemia cell line THP-1Biochemical and Biophysical Research Communications, 1987
- Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibinNature, 1986
- Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluidNature, 1986
- Inhibin and beta type transforming growth factor (TGFβ) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cellsBiochemical and Biophysical Research Communications, 1986
- Type beta transforming growth factor (TGF-β) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer systemBiochemical and Biophysical Research Communications, 1986